News | May 28, 2026
Morepen Labs posts strong Q4 FY26 net profit
For the full year, standalone gross revenue crossed Rs. 1,700 crore
For the full year, standalone gross revenue crossed Rs. 1,700 crore
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
This multi-year CDMO agreement involves significant, ongoing manufacturing for a global pharmaceutical major
Morepen Laboratories has reported total income of Rs. 429.64 crores during the period ended June 30, 2025
The company has posted net profit of Rs. 118.01 crores for the Financial Year ended March 31, 2025
Morepen Laboratories approves hiving off of medical devices business
He holds a Master’s in Management from the National University of Singapore
Morepen Labs successfully raised Rs. 200 Crore through QIP
Sharma joined the Morepen Lab in 2004
Morepen Laboratories has reported total income of Rs. 448.62 crores during the period ended December 31, 2023
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
